CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat beta-Thalassemia. (nejm.org)

Authors: Frangoul H … Thompson A Journal: New England Journal of Medicine Published: 2026-04-02 DOI: https://doi.org/10.1056/NEJMoa2501277